Cadence Bank reduced its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI – Free Report) by 2.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 19,960 shares of the real estate investment trust’s stock after selling 606 shares during the quarter. Cadence Bank’s holdings in Omega Healthcare Investors were worth $812,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Versant Capital Management Inc bought a new position in Omega Healthcare Investors in the second quarter valued at about $26,000. UMB Bank n.a. lifted its holdings in Omega Healthcare Investors by 353.4% in the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 516 shares during the period. DiNuzzo Private Wealth Inc. bought a new position in Omega Healthcare Investors in the third quarter valued at about $33,000. V Square Quantitative Management LLC lifted its holdings in Omega Healthcare Investors by 49.5% in the third quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock valued at $40,000 after acquiring an additional 323 shares during the period. Finally, Truvestments Capital LLC bought a new position in Omega Healthcare Investors in the third quarter valued at about $43,000. 65.25% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
OHI has been the subject of a number of analyst reports. BMO Capital Markets increased their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research note on Monday, October 7th. BNP Paribas upgraded shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target on the stock in a report on Thursday, October 31st. Truist Financial increased their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a report on Wednesday, September 4th. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Finally, Scotiabank boosted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, Omega Healthcare Investors presently has a consensus rating of “Hold” and a consensus price target of $40.00.
Insider Buying and Selling at Omega Healthcare Investors
In other news, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This represents a 36.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. This represents a 10.96 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.37% of the company’s stock.
Omega Healthcare Investors Trading Down 0.2 %
Shares of OHI stock opened at $40.68 on Thursday. Omega Healthcare Investors, Inc. has a 1 year low of $27.53 and a 1 year high of $44.42. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. The stock’s 50 day simple moving average is $40.60 and its two-hundred day simple moving average is $37.21. The company has a market cap of $10.98 billion, a PE ratio of 29.91, a price-to-earnings-growth ratio of 1.25 and a beta of 0.99.
Omega Healthcare Investors Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were given a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.59%. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 197.06%.
About Omega Healthcare Investors
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
Featured Articles
- Five stocks we like better than Omega Healthcare Investors
- Want to Profit on the Downtrend? Downtrends, Explained.
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What is a Dividend King?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Technology Stocks Explained: Here’s What to Know About Tech
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI – Free Report).
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.